Yong Li

23PUBLICATIONS
77CO-AUTHORS
Disease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersBiomaterialsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|May 05, 2026
Targeting DOT1L Reactivates HERV-K to Drive Cell-Autonomous and Paracrine Senescence in Adenocarcinoma of the Esophagogastric Junction.

|Feb 26, 2026
Consensus guidance of immune checkpoint inhibitors in locally advanced rectal cancer.

Zhengyang Yang, Fan Xia, Jian Li

|Feb 19, 2026
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial.

Wei-Jian Mei, Xiao-Zhong Wang, Xuan Zhang

|Jan 29, 2026
Prospective evaluation of radical surgery for adenocarcinoma of oesophagogastric junction: real-world insights from the CLAEG study.

Jiabin Zheng, Yuanfang Li, Lin Fan

|Jan 26, 2026
Stenotrophomonas promotes gastrointestinal tumor progression via STING degradation in tumour cells and mitigated immune response.

Huolun Feng, Kunling Chen, Zhihui Xi

|Dec 10, 2025
Fluidic microgel assemblies with enhanced oral delivery of biologics alleviate colonic inflammation in murine and canine models.

Qingqiao Xie, Chenchen Yan, Zifeng Yang

Pageof 4

Frequent Collaborators

5 joint publications

Huolun Feng

3 joint publications

Jiabin Zheng

2 joint publications

Fa Ling

2 joint publications

Junjiang Wang